Derek John Saunders

This inventor holds 22 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Gruenenthal Gmbh, Medifron Dbt Inc.. Active years: 1997-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Derek John Saunders. Retrieved from https://idiyas.com/inventor/derek-john-saunders

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 3)

% Patents Active = 27.3

CIPO Patents = 2

EPO Patents = 10 (Patent Applications = 13)

Average Co-Inventor Count = 7.4

ph-index = 6

Forward Citations = 101(Granted Patents)

Company Filing History:

Years Active: 1997-2017

Loading Chart...

Areas of Expertise:

Vanilloid Receptor Ligands

Pharmaceutical Compositions

Spirocyclic Compounds

Phenylureas

Cyclohexyldiamines

Urokinase Variants

Pain Treatment

Anti-Depressants

Fibrinolytic

Carboxamide Derivatives

Urea Derivatives

3-Pyridyl Compounds

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9771359 - Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II (2017-09-26),

2. 9624209 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2017-04-18),

3. 9120756 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2015-09-01),

4. 8946204 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2015-02-03),

5. 8895623 - Intrathecal or epidural administration of 3-[(1S,25)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol (2014-11-25),

6. 8791268 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions (2014-07-29),

7. 8785474 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions (2014-07-22),

8. 8735426 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them and use thereof for treating pain and other conditions (2014-05-27),

9. 8710233 - Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations (2014-04-29),

10. 8642775 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions (2014-02-04),

11. 8642623 - Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions (2014-02-04),

12. 8592471 - Substituted phenylureas and phenylamides as vanilloid receptor ligands (2013-11-26),

13. 8404740 - Spirocyclic cyclohexane compounds (2013-03-26),

14. 8357705 - Substituted cyclohexyldiamines (2013-01-22),

15. 8278338 - Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety (2012-10-02),

Title: Derek John Saunders - Innovative Inventor from Aachen

Introduction: Derek John Saunders is a renowned inventor based in Aachen, Germany, known for his groundbreaking contributions to various industries.

Latest Patents: Derek John Saunders holds several patents in the fields of renewable energy, sustainable technology, and advanced materials.

Career Highlights: With a career spanning over two decades, Derek John Saunders has worked with leading research institutions and universities to develop cutting-edge solutions for global challenges.

Collaborations: Throughout his career, Derek John Saunders has collaborated with top companies, innovative startups, and talented individuals to bring his inventions to life and make a positive impact on society.

Conclusion: Derek John Saunders continues to push the boundaries of innovation, inspiring the next generation of inventors with his passion for creating a better future through technology.

Profile summary based on public USPTO records.